Search - tctmd.com

Displaying 641 - 660 of 2765

Sort: Relevancy | Date

News Daily News

USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits

Michael O'Riordan

July 27, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Todd Neale

July 20, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Shelley Wood

July 07, 2022

News Daily News

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

Michael O'Riordan

July 06, 2022

News Daily News

Weekend Warriors vs Regular Exercisers: Some Insights, More Questions

Yael L. Maxwell

July 06, 2022

News Daily News

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

Todd Neale

July 04, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for June Week 4

Todd Neale

June 20, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Caitlin E. Cox

June 10, 2022

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

Advertisement

USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

High Lp(a) May Predict Risk of CV and Limb Events in PAD

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

Weekend Warriors vs Regular Exercisers: Some Insights, More Questions

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

July 2022 News Roundup

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

COVID-19: TCTMD’s Dispatch for June Week 4

Minorities, Poorer Patients Missing Out on Structural Heart Care

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content